FDA Takes Key Action by Approving Second COVID-19 Vaccine
Today (January 31, 2022), the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.
Life Sciences Corridor
This page describes information about the Cambridge, Boston, Somerville, and Quincy life sciences corridor
City Program Administers over 11,000 Free COVID-19 Tests
The City of Cambridge has provided over 11,000 free COVID-19 tests to people in Cambridge since last spring through its mobile testing program. Residents can get tested regardless of whether they have symptoms or feel ill. No health insurance or ID is required.
Update on Cambridge being Recategorized as Moderate Risk Community
On Thursday, October 22, the Massachusetts Department of Public Health recategorized the City of Cambridge as a moderate risk “yellow” community. This designation is given to communities where the average daily case rate over the last 14 days is 4-8 cases per 100,000 population.